FDP mentioned in Barron's:
<RS Partners' small-cap value fund top holding is Fresh Del Monte Produce, the fruit and vegetable company. The company met his requirement for managing capital, because he estimates that it will have a return on capital of 13%, a healthy seven basis points -- each equal to 1/100th of a percentage point -- above its cost of capital.
In contrast, he calculates, the average industrial company in the U.S. has a return on capital of less than 7%.
"It wasn't recognized because it was seen as a banana company," Pilara says, "but it's generating all this free cash flow."
He bought the stock in 2001 when it was at $4; it recently traded at more than $27. Pilara didn't try to time his investment in Fresh Del Monte, just as he doesn't need a specific catalyst for a stock to make it into his fund. As he said, he's a business analyst.>
MDCO - hit a new 52 week high last week. Earnings came in at the low end of expectations. Angiomax revenues weren't as brisk as I expected. Results from the REPLACE-2 clinical trial, which are expected soon, are likely to affect forecasts.
HL missed analyst earnings estimates but established higher revenue growth and higher profits. HL should continue to perform in line with gold prices.
CLGY earnings released this morning. Teleconference follows in a few hours. New financing is a major score for this company. A marketing agreement for Tostrex can't be far away.
. |
